BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification When will the FDA reclassify BPC 157 to Category 1 Octagon AI Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to The Human Lab Rats Injecting Themselves with Peptides Office for Science and Society McGill University Healing Ankle Injuries: PRP vs BPC 157 & Regenerative Medicine